Trials / Completed
CompletedNCT00250445
A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)
A Randomized, Double-Blind, Active-Comparator-Controlled, Parallel-Group Study to Evaluate the Safety of Etoricoxib in Patients With Osteoarthritis or Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 23,498 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to compare the risk of cardiovascular events (heart attacks, strokes) in patients receiving either etoricoxib or diclofenac. It will also compare the gastrointestinal tolerability of the two medicines. The study will be conducted in patients with either rheumatoid or osteo-arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0663, etoricoxib | |
| DRUG | Comparator: Diclofenac sodium |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2006-05-01
- Completion
- 2006-05-01
- First posted
- 2005-11-08
- Last updated
- 2022-02-18
Source: ClinicalTrials.gov record NCT00250445. Inclusion in this directory is not an endorsement.